Evidence map›Paper›PMID 12453364›Full record

ArticleEmerging infectious diseases2002

Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family.

Francis Drobniewski, Yanina Balabanova, Michael Ruddy, Laura Weldon, Katya Jeltkova, Timothy Brown, Nadezdna Malomanova, Elvira Elizarova, Alexander Melentyey, Ebgeny Mutovkin and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Beijing genotype ofNew microbes and new infections · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Francis DrobniewskiGuy's King's amd St Thomas' Medical School, King's College Hospital, London, United Kingdom. francis.drobniewski@kcl.ac.uk
Yanina Balabanova
Michael Ruddy
Laura Weldon
Katya Jeltkova
Timothy Brown
Nadezdna Malomanova
Elvira Elizarova
Alexander Melentyey
Ebgeny Mutovkin
Svetlana Zhakharova
Ivan Fedorin
University of Cambridge · GBSamara Regional Clinical Oncology Center · RUCentral Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and previous therapy in drug resistance. Rifampin, isoniazid, and multidrug resistance occurred in 58.2%, 51.6%, and 44.7% of cultures, respectively; 80% of prison cultures were rifampin resistant. Spoligotyping and variable number tandem repeat (VNTR) fingerprinting divided the isolates into 43 groups. Spoligotyping demonstrated that a high proportion (68.1%) of patients were infected with Beijing family strains and that most (69.1%) were rifampin resistant; the highest proportion (81.6%) occurred in prison. One VNTR subgroup (42435) comprised 68 (72.3%) of the Beijing isolates with a small number of IS6110 types; 50 (73.5%) were rifampin resistant. Rifampin-resistant Beijing isolates are dominant within the patient population, especially among prisoners, and threaten treatment programs.

Indexed as

Drug Resistance, Multiple, BacterialPrisonersAntitubercular AgentsChinaFemaleHumansMaleMinisatellite RepeatsMutationMycobacterium tuberculosisRifampinRussiaTuberculosisAntitubercular AgentsRifampin

Identifiers

PMID12453364
PMCPMC2738537
OpenAlexW2063529786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.